BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 7677966)

  • 1. A short-term trial of butyrate to stimulate fetal-globin-gene expression in the beta-globin disorders.
    Perrine SP; Ginder GD; Faller DV; Dover GH; Ikuta T; Witkowska HE; Cai SP; Vichinsky EP; Olivieri NF
    N Engl J Med; 1993 Jan; 328(2):81-6. PubMed ID: 7677966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extended therapy with intravenous arginine butyrate in patients with beta-hemoglobinopathies.
    Sher GD; Ginder GD; Little J; Yang S; Dover GJ; Olivieri NF
    N Engl J Med; 1995 Jun; 332(24):1606-10. PubMed ID: 7753139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Butyrate derivatives. New agents for stimulating fetal globin production in the beta-globin disorders.
    Perrine SP; Olivieri NF; Faller DV; Vichinsky EP; Dover GJ; Ginder GD
    Am J Pediatr Hematol Oncol; 1994 Feb; 16(1):67-71. PubMed ID: 7508690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease.
    Rodgers GP; Dover GJ; Uyesaka N; Noguchi CT; Schechter AN; Nienhuis AW
    N Engl J Med; 1993 Jan; 328(2):73-80. PubMed ID: 7677965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversing ontogeny.
    Bunn HF
    N Engl J Med; 1993 Jan; 328(2):129-31. PubMed ID: 7677964
    [No Abstract]   [Full Text] [Related]  

  • 6. Post-transcriptional effects of interleukin-3, interferon-gamma, erythropoietin and butyrate on in vitro hemoglobin chain synthesis in congenital hemolytic anemia.
    Reinhardt D; Ridder R; Kugler W; Pekrun A
    Haematologica; 2001 Aug; 86(8):791-800. PubMed ID: 11522534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in protein-DNA interactions in the gamma-globin gene promoter in response to butyrate therapy.
    Ikuta T; Kan YW; Swerdlow PS; Faller DV; Perrine SP
    Blood; 1998 Oct; 92(8):2924-33. PubMed ID: 9763579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent sickle-cell anemia and alpha-thalassemia: effect on severity of anemia.
    Embury SH; Dozy AM; Miller J; Davis JR; Kleman KM; Preisler H; Vichinsky E; Lande WN; Lubin BH; Kan YW; Mentzer WC
    N Engl J Med; 1982 Feb; 306(5):270-4. PubMed ID: 6172710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular and molecular effects of a pulse butyrate regimen and new inducers of globin gene expression and hematopoiesis.
    Ikuta T; Atweh G; Boosalis V; White GL; Da Fonseca S; Boosalis M; Faller DV; Perrine SP
    Ann N Y Acad Sci; 1998 Jun; 850():87-99. PubMed ID: 9668531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Butyrate increases the efficiency of translation of gamma-globin mRNA.
    Weinberg RS; Ji X; Sutton M; Perrine S; Galperin Y; Li Q; Liebhaber SA; Stamatoyannopoulos G; Atweh GF
    Blood; 2005 Feb; 105(4):1807-9. PubMed ID: 15479724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of the clinical severity of sickle cell/beta-thalassemia with hydroxyurea: the experience of a single center in Greece.
    Loukopoulos D; Voskaridou E; Kalotychou V; Schina M; Loutradi A; Theodoropoulos I
    Blood Cells Mol Dis; 2000 Oct; 26(5):453-66. PubMed ID: 11112383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-azacytidine selectively increases gamma-globin synthesis in a patient with beta+ thalassemia.
    Ley TJ; DeSimone J; Anagnou NP; Keller GH; Humphries RK; Turner PH; Young NS; Keller P; Nienhuis AW
    N Engl J Med; 1982 Dec; 307(24):1469-75. PubMed ID: 6183586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential regulation of A gamma and G gamma fetal hemoglobin mRNA levels by hydroxyurea and butyrate.
    Xu J; Zimmer DB
    Exp Hematol; 1998 Mar; 26(3):265-72. PubMed ID: 9502623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Butyrate-induced reactivation of the fetal globin genes: a molecular treatment for the beta-hemoglobinopathies.
    Perrine SP; Faller DV
    Experientia; 1993 Feb; 49(2):133-7. PubMed ID: 7680003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic induction of fetal hemoglobin synthesis: cellular and molecular mechanisms.
    Yang YM; Pace B
    Pediatr Pathol Mol Med; 2001; 20(1):87-106. PubMed ID: 12673846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxamide derivatives of short-chain fatty acid have erythropoietic activity and induce gamma gene expression in vivo.
    Cao H; Jung M; Stamatoyannopoulos G
    Exp Hematol; 2005 Dec; 33(12):1443-9. PubMed ID: 16338486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythroid marrow activity and functional anemia in patients with the rare interaction of a single functional a-globin and beta-globin gene.
    Traeger-Synodinos J; Papassotiriou I; Vrettou C; Skarmoutsou C; Stamoulakatou A; Kanavakis E
    Haematologica; 2001 Apr; 86(4):363-7. PubMed ID: 11325640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isobutyramide, an orally bioavailable butyrate analogue, stimulates fetal globin gene expression in vitro and in vivo.
    Perrine SP; Dover GH; Daftari P; Walsh CT; Jin Y; Mays A; Faller DV
    Br J Haematol; 1994 Nov; 88(3):555-61. PubMed ID: 7529533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Butyrate in the treatment of sickle cell disease and beta-thalassemia.
    Faller DV; Perrine SP
    Curr Opin Hematol; 1995 Mar; 2(2):109-17. PubMed ID: 9371980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of fetal hemoglobin production by short chain fatty acids.
    Liakopoulou E; Blau CA; Li Q; Josephson B; Wolf JA; Fournarakis B; Raisys V; Dover G; Papayannopoulou T; Stamatoyannopoulos G
    Blood; 1995 Oct; 86(8):3227-35. PubMed ID: 7579419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.